MedPath

Glucose

Generic Name
Glucose
Brand Names
Bss Ophthalmic Solution, Citrasate, Clinimix 2.75/5, Clinimix E 2.75/5, Dextroject, Dianeal, H.E.L.P.bicel, Hemosate Ultra, Lactate 1-2-3, Leukotrap, Naturalyte, Nauzene, Normosol-R, Nxstage Pureflow, Olimel, Periolimel, Physioneal 40, Sag-M, Sclerodex, Selectbag One
Drug Type
Small Molecule
Unique Ingredient Identifier
IY9XDZ35W2
Background

Glucose is a simple sugar (monosaccharide) generated during phosynthesis involving water, carbon and sunlight in plants. It is produced in humans via hepatic gluconeogenesis and breakdown of polymeric glucose forms (glycogenolysis). It circulates in human circulation as blood glucose and acts as an essential energy source for many organisms through aerobic or anaerobic respiration and fermentation. It is primarily stored as starch in plants and glycogen in animals to be used in various metabolic processes in the cellular level. Its aldohexose stereoisomer, dextrose or D-glucose, is the most commonly occurring isomer of glucose in nature. L-glucose is a synthesized enantiomer that is used as a low-calorie sweetener and laxative. The unspecified form of glucose is commonly supplied as an injection for nutritional supplementation or metabolic disorders where glucose levels are improperly regulated. Glucose is listed on the World Health Organization's List of Essential Medicines.

Indication

Glucose pharmaceutical formulations (oral tablets, injections) are indicated for caloric supply and carbohydrate supplementation in case of nutrient deprivation. It is also used in metabolic disorders such as hypoglycemia.

Associated Conditions
Arrhythmia, Caloric Deficit, Edema of the cerebrum, Hypoglycemia, Metabolic Alkalosis
Associated Therapies
Blood Specimen Collection, Electrolyte replacement, Nutritional supplementation, Parenteral Nutrition, Parenteral rehydration therapy, Plasmapheresis, Positive cardiac inotropic effect, Total parenteral nutrition therapy, Urine alkalinization therapy, Fluid and electrolyte maintenance therapy

Pre-emptive Analgesia Effect in Different Psycho-emotional Status Patients During Lower Third Molar Surgical Extractions

Not Applicable
Completed
Conditions
Pre-emptive Analgesia in Different Psycho-emotional Status Patients
Interventions
First Posted Date
2019-12-17
Last Posted Date
2019-12-17
Lead Sponsor
Lithuanian University of Health Sciences
Target Recruit Count
45
Registration Number
NCT04202224
Locations
🇱🇹

Lithuanian university of health sciences, Kaunas, Lithuania

High Protein Formula on Enteral Feeding in Clinical Improvement and Malnutrition at Intensive Care Unit Patients

Not Applicable
Completed
Conditions
Critically Ill
Intensive Care Unit
Interventions
Other: High Protein Polymeric Formula
Other: Oligomeric Formula
Drug: 5% Dextrose
First Posted Date
2019-11-05
Last Posted Date
2019-11-05
Lead Sponsor
Hasanuddin University
Target Recruit Count
60
Registration Number
NCT04150978
Locations
🇮🇩

Wahidin Sudirohusodo General Hospital, Makassar, South Sulawesi, Indonesia

Effect of GLP-1 on Microvascular Insulin Responses in Type 1 Diabetes

Early Phase 1
Withdrawn
Conditions
Type 1 Diabetes
Insulin Sensitivity/Resistance
Interventions
Drug: Dextrose 20 % in Water
First Posted Date
2019-10-21
Last Posted Date
2022-03-22
Lead Sponsor
University of Virginia
Registration Number
NCT04133922
Locations
🇺🇸

University of Virginia, Charlottesville, Virginia, United States

Dynamic Connectivity Under Metabolic Constraints

Phase 4
Conditions
Diet Modification
Aging
Insulin Resistance
Healthy
Interventions
Drug: Ketones
First Posted Date
2019-09-27
Last Posted Date
2019-09-27
Lead Sponsor
Stony Brook University
Target Recruit Count
80
Registration Number
NCT04106882
Locations
🇺🇸

Bioengineering Building , Stony Brook University, Stony Brook, New York, United States

🇺🇸

Martinos Center for Biomedical Research, Building 149, Charlestown, Massachusetts, United States

Injection of Subcutaneous Glucose 10% in Small Shots is Effective in the Treatment of Diabetic Neuropathic Pain

Completed
Conditions
Painful Diabetic Neuropathy
Interventions
Drug: GLUCOSE 10%
First Posted Date
2019-09-20
Last Posted Date
2020-05-07
Lead Sponsor
Ministry of Health and Population, Egypt
Target Recruit Count
100
Registration Number
NCT04097691
Locations
🇪🇬

Mahmoud Younis, Cairo, Egypt

The Effect of Intradialytic Parenteral Nutrition on Nutritional Status and Quality of Life in Hemodialysis Patients

Phase 4
Active, not recruiting
Conditions
End Stage Renal Disease
Malnutrition
Sarcopenia
Hemodialysis Complication
Interventions
Drug: Glucose IV
First Posted Date
2019-09-18
Last Posted Date
2024-12-27
Lead Sponsor
Erasmus Medical Center
Target Recruit Count
166
Registration Number
NCT04094038
Locations
🇳🇱

Erasmus MC, Rotterdam, Netherlands

🇳🇱

Franciscus Gasthuis & Vlietland, Rotterdam, Netherlands

High-dose Intravenous Vitamin C as an Adjunctive Treatment for Sepsis in Rwanda

Phase 3
Withdrawn
Conditions
Sepsis
Interventions
Drug: Dextrose in Water
Drug: Ascorbic Acid 500Mg/Ml Inj
First Posted Date
2019-09-13
Last Posted Date
2022-10-18
Lead Sponsor
Virginia Commonwealth University
Registration Number
NCT04088591
Locations
🇷🇼

University Teaching Hospital of Kigali, Kigali, Rwanda

Intravenous (IV) Hydrocortisone for TKA (Total Knee Arthroplasty)

Phase 4
Active, not recruiting
Conditions
Pain
Arthrofibrosis
Osteoarthritis, Knee
Interventions
Drug: Dextrose 5% in water (D5W)
First Posted Date
2019-09-09
Last Posted Date
2024-08-22
Lead Sponsor
Hospital for Special Surgery, New York
Target Recruit Count
132
Registration Number
NCT04082533
Locations
🇺🇸

Hospital for Special Surgery, New York, New York, United States

Prolotherapy for the Treatment of Partial Rotator Cuff Tears

Phase 4
Withdrawn
Conditions
Rotator Cuff Tear
Interventions
Drug: Dextrose 50
First Posted Date
2019-08-20
Last Posted Date
2022-08-23
Lead Sponsor
Hadassah Medical Organization
Registration Number
NCT04062838
Locations
🇮🇱

Pain Unit, Hadassah Medical Center, Jerusalem, Israel

The Impact of a Preoperative Nerve Block in Foot and Ankle Surgery on the Consumption of Sevoflurane

Phase 2
Withdrawn
Conditions
Anesthesia; Functional
Ankle Arthropathy
Ankle Arthritis
Interventions
First Posted Date
2019-07-16
Last Posted Date
2024-06-06
Lead Sponsor
University of Alberta
Registration Number
NCT04022057
Locations
🇨🇦

University of Alberta Hospital, Edmonton, Alberta, Canada

© Copyright 2025. All Rights Reserved by MedPath